Event Information

產業會議彙總曆

Well Characterized Biologicals

Event Information

從實際的個案研究來學習分析策略及預見法規改變

Well Characterized Biologicals(充分特性化的生物製劑:2011年學會)
2011年10月3日 - 5日, Omni Shoreham Washington, DC

諮詢委員會

Izydor Apostol, Ph.D., Scientific Director, Analytical and Formulation Sciences, Amgen, Inc.

John P. Hennessey, Jr., Ph.D., Vice President, Research & Development, NovaDigm Therapeutics, Inc.

Alan V. Klotz, Ph.D., Research Advisor/CM&C Leader, Elanco Biosciences

Joseph Kutza, Ph.D., Director, CMC Regulatory Affairs, MedImmune, Inc.

Ned Mozier, Ph.D., Senior Director, Analytical Sciences, Global Biologics Research and Development, Pfizer, Inc.

Michael G. Mulkerrin, Ph.D., Vice President, Process Development, OncoMed Pharmaceuticals

Nadine M. Ritter, Ph.D., Senior CMC Consultant, Biologics Consulting Group

John Stults, Ph.D., Director of Protein Analytical Chemistry-2, Genentech, Inc.

Copyright IBC Life Sciences, a part of Informa Life Sciences Group | 中文官方網站營運:IBC Life Sciences 代理商 日商環球訊息有限公司

Powered by Interactive Agency Janmedia Interactive, Inc.